It mimics the GLP-1 hormone, slowing digestion, reducing appetite, and stabilizing blood sugar
Mounjaro became available through primary care in June 2025 as part of a phased rollout, initially for people with a BMI of 40 or above and at least four weight-related health conditions
Effective management can improve the patients comfort and enhance adherence to the medication, thereby optimizing its therapeutic benefits
J Agro Crop Sci 16(247):562570
So, if youve put on weight this year, remember your excuse: Losing weight
By suppressing glucagon, semaglutide prevents the liver from releasing too much sugar and keeps blood sugar more stable after eating